Regional chemotherapy of cancer of the head and neck.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D010478:Chemotherapy, Cancer, Regional Perfusion; D005472:Fluorouracil / Q000008:administration & dosage; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009062:Mouth Neoplasms / Q000188:drug therapy*; D009303:Nasopharyngeal Neoplasms; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy*; D012509:Sarcoma / Q000188:drug therapy; D013852:Thiotepa / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014747:Vinblastine; D013852:Thiotepa; D008558:Melphalan; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate